Murray Hill and New Providence, New Jersey, U.S., April 18, 2013–Linde North America invites pharmaceutical manufacturers and biotech companies to visit its booth at this year’s BIO International Convention 2013. Linde cryogenic gases experts will be featuring technologies to help them meet production and environmental requirements, as well as introduce a complete line of specimen cryopreservation services.
At booth C8 in the Bio Partner Pavilion (3651) at McCormick Place in Chicago, Illinois, April 22-25, 2013, Linde representatives will discuss how these technical capabilities can improve the quality, productivity and cost-effectiveness of pharmaceutical, biotech and R&D operations.
Linde North America is a member of The Linde Group, a world-leading gases and engineering company. The Biotechnology Industry Organization (BIO), founded in 1993, represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the U.S. and in more than 30 other nations.
Linde is a BIO Business Solutions Partner, offering member companies special pricing and rebates on bulk gas products, bulk gas applications, packaged and specialty gases, mini-bulk and related equipment, products and services. The gases covered include cylinder supply for industrial and special gas requirements, on-site generators for nitrogen, oxygen and hydrogen, and liquid supply capabilities for argon, nitrogen, oxygen, carbon dioxide, hydrogen and helium.
Linde Cryoservices™ program is specially designed to service all the needs of organizations that need to cryogenically store irreplaceable specimens, such as cord blood, bone marrow, cell lines, blood and organs for transfusion and transplantation. Visitors at the BIO International Convention can meet with Linde specialists to discuss these capabilities - from specialized equipment to a complete line of cryopreservation services– virtually anywhere in the U.S.
Don Bongarzone, Linde Cryoservices manager-North America, said, “Linde’s extensive liquid nitrogen supply network, combined with our wealth of experience in the medical/pharmaceutical industry, provides customers with the security of product supply they need and the services that will assure the safe, long-term preservation and distribution of these irreplaceable materials.”
The Linde Group is a world-leading gases and engineering company with around 62,000 employees in more than 100 countries worldwide. In the 2012 financial year, Linde generated revenue of EUR 15.280 bn (USD 19.9 bn). The strategy of the Group is geared towards long-term profitable growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment – in every one of its business areas, regions and locations across the globe. The company is committed to technologies and products that unite the goals of customer value and sustainable development.
For more information, see The Linde Group online at www.linde.com
Linde corporate communications